Literature DB >> 14581085

32P liquid sources--comparison of the effectiveness of postangioplasty versus poststenting intravascular brachytherapy in hypercholesterolemic rabbits. Adjunctly implanted titanium stent does not attenuate the effect of endovascular irradiation.

Piotr Walichiewicz1, Barbara Petelenz, Krzysztof Wilczek, Wojciech Jacheć, Jerzy Jochem, Andrzej Tomasik, Dariusz Lange, Jan Wodniecki.   

Abstract

PURPOSE: Endovascular application of ionizing radiation is a promising but still not sufficiently studied means of restenosis prevention. To test the effects of radiation on restenosis, and especially their dependence on whether the angioplasty was followed by stent implantation or not, we performed an in-stent versus no-stent intravascular brachytherapy study in an animal model. Balloon-based, continuous and self-centering, liquid 32P sources seemed the most convenient for the purpose.
METHOD: The radial dose distribution around angioplasty balloons filled with solutions of Na(2)H32PO(4) was calibrated by thermoluminescence dosimetry, both in the absence and presence of stents. The animal experiments were performed on rabbits with induced hypercholesterolemia. The balloons containing 32P were introduced into iliac artery immediately after stent implantation or after angioplasty alone. Radiation effects were evaluated postmortem by comparing thickness of various components of the artery wall.
RESULTS: In the presence of titanium stents (TTS), irradiation with 16 Gy dose at 1.0 mm from the balloon surface was no less effective in reducing hypertrophy in every active layer of the artery wall than without a stent.
CONCLUSION: In the animal model, IVBT basing on P(32) liquid sources was no less effective in the stented arteries than in the nonstented ones.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14581085     DOI: 10.1016/s1522-1865(03)00145-8

Source DB:  PubMed          Journal:  Cardiovasc Radiat Med        ISSN: 1522-1865


  2 in total

1.  Monte Carlo dosimetric parameter study of a new (32)P brachytherapy source.

Authors:  Junxiang Wu; Jing Huang; Fengxiang Long; Chengkai Wang; Zhangwen Wu; Chengjun Gou
Journal:  Br J Radiol       Date:  2016-04-04       Impact factor: 3.039

2.  Monte Carlo dosimetry of a new (90)Y brachytherapy source.

Authors:  Wu Junxiang; You Shihu; Huang Jing; Long Fengxiang; Wang Chengkai; Wu Zhangwen; Hou Qing; Gou Chengjun
Journal:  J Contemp Brachytherapy       Date:  2015-10-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.